Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Martinelli

Showing results (121-130 of 191) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Nutrition|September 16, 2010
Impact of maternal vitamin A supplementation on the mother-infant pair in BrazilT M Martins, I S Ferraz, J C Daneluzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2016
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsiesM Petrillo, G F Zannoni, L Beltrame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectivesE Martinelli, D Ciardiello, G Martini, et al.
Scientific Reports|May 8, 2020
Discovering the hidden messages within cell trajectories using a deep learning approach for in vitro evaluation of cancer drug treatmentsA Mencattini, D Di Giuseppe, M C Comes, et al.
British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.
ESMO Open|February 18, 2021
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in ItalyR Berardi, M Torniai, M S Cona, et al.
Il Giornale Di Chirurgia|March 1, 2011
[Overexpression of laminine-5( LN-5) in peritoneal lavage of colorectal cancer patients preliminary results]A Volpi, G D'Elia, O C Pannarale, et al.
The Journal of Frailty & Aging|May 10, 2018
Polypharmacy but not Potential Inappropriate Prescription Was Associated with Frailty in Older Adults from a Middle-Income Country Outpatient ClinicI Aprahamian, M M Biella, G Vano Aricó de Almeida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trialN Normanno, A M Rachiglio, M Lambiase, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation studyJ Tabernero, F Ciardiello, F Rivera, et al.
Pageof 20

Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Nutrition|September 16, 2010
Impact of maternal vitamin A supplementation on the mother-infant pair in BrazilT M Martins, I S Ferraz, J C Daneluzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2016
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsiesM Petrillo, G F Zannoni, L Beltrame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectivesE Martinelli, D Ciardiello, G Martini, et al.
Scientific Reports|May 8, 2020
Discovering the hidden messages within cell trajectories using a deep learning approach for in vitro evaluation of cancer drug treatmentsA Mencattini, D Di Giuseppe, M C Comes, et al.
British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.
ESMO Open|February 18, 2021
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in ItalyR Berardi, M Torniai, M S Cona, et al.
Il Giornale Di Chirurgia|March 1, 2011
[Overexpression of laminine-5( LN-5) in peritoneal lavage of colorectal cancer patients preliminary results]A Volpi, G D'Elia, O C Pannarale, et al.
The Journal of Frailty & Aging|May 10, 2018
Polypharmacy but not Potential Inappropriate Prescription Was Associated with Frailty in Older Adults from a Middle-Income Country Outpatient ClinicI Aprahamian, M M Biella, G Vano Aricó de Almeida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trialN Normanno, A M Rachiglio, M Lambiase, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation studyJ Tabernero, F Ciardiello, F Rivera, et al.
Pageof 20